Biotech Values

[rkrw]

You need to consider "cost to cure." Insurers may have something else in mind.

Provided TMC435 and 7977 make it to market, even in the absence of the FDA formally approving the combo and in the absence of any formal deal between the two companies, it's likely doctors will prescribe the drugs in combo anyways.